The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and ...
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00.
Analyst Chris Schott from J.P. Morgan maintained a Hold rating on Pfizer (PFE – Research Report) and keeping the price target at $30.00.
The CDC has just announced a second shot for elders and the immunocompromised people – but when’s the best time?
Pfizer Chairman and CEO Albert Bourla joins 'Mad Money' host Jim Cramer to talk quarterly results, what's in the pipeline, ...
UK High Court judge unconvinced by Pfizer that uniQure’s patent is invalid | Companies in dispute over patents covering ...
Pfizer had a "constructive" meeting with activist investor Starboard Value last week and spoke publicly about it for the ...
Pfizer reported an earnings beat Tuesday morning and raised its full-year outlook, seeing strength in sales of its Covid ...
If you’re looking for a rewarding but relatively safe haven for your money amid pre-election stock market volatility—and ...
NEW YORK — A boost from Covid-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher ...
With changing recommendations and multiple seasonal viruses to contend with, here’s your simple guide to the 2024-2025 cold and flu season and when to call your doctor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback